Woman seriously injured by vehicle in Midtown hit-and-run, Anchorage police say
Jun. 1—A vehicle struck a woman in a hit-and-run early Saturday in Midtown Anchorage, sending her to the hospital with serious injuries, police said.
Multiple people called police around 3:04 a.m. Saturday to report a woman who was lying in the road near the Seward Highway and East Benson Boulevard, the Anchorage Police Department said in a later update to a post on its website.
"Witnesses stated that the adult female had been struck by a vehicle, which then fled the scene," police said in the update.
The woman was taken to the hospital with injuries that police described as life-threatening.
The northbound lanes of the Seward Highway between East 36th Avenue and Benson were closed for several hours Saturday as police processed the scene.
Police said the investigation into the incident is ongoing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
13 minutes ago
- CNN
The Met's Rockefeller Wing reopens after $70M revamp
Once labeled 'primitive," the Met's collection of art from Africa, Oceania and the Americas now has pride of place in the museum's newly renovated Rockefeller Wing.
News24
an hour ago
- News24
Kevin Costner sued for allegedly forcing a stuntwoman to perform violent rape scene
Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once. Start your FREE trial now
Associated Press
an hour ago
- Associated Press
Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference
BOULDER, Colo., June 3, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the Annual Goldman Sachs Global Healthcare Conference on Monday, June 9, 2025 at 3:20 pm ET. The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference. It is recommended that users connect to the live webcast several minutes prior to the start to ensure a timely connection. About Edgewise Therapeutics Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company's deep expertise in muscle physiology is driving a new generation of novel therapeutics. Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, currently in Phase 2 clinical development. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: or follow us on LinkedIn, X , Facebook and Instagram. View original content to download multimedia: SOURCE Edgewise Therapeutics
